LF
CALA

Lee Financial’s Calithera Biosciences, Inc CALA Stock Holding History

Lee Financial’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5
Closed -$2K – 516
2017
Q3 		$2K Hold
5
– – ﹤0.01% 458
2017
Q2 		$1K Buy
+5
New +$1.34K ﹤0.01% 492

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

Lee Financial's CALA Position: Q4 2017 in Review

Lee Financial sold out of Calithera Biosciences, Inc (CALA) in Q4 2017, closing a stake of 5 shares — an estimated $2K sold.

Lee Financial first reported a position in CALA in Q2 2017 and held it in 2 quarters. The position peaked at $2K in Q3 2017. 112 funds tracked by Wall St. Rank hold CALA as of Q4 2017.

  • Lee Financial reported no remaining Calithera Biosciences, Inc position as of Q4 2017 after selling out during the quarter.
  • Lee Financial sold 5 Calithera Biosciences, Inc shares in Q4 2017, an estimated $2K.
  • Lee Financial first reported a position in Calithera Biosciences, Inc in Q2 2017 and held it in 2 quarters.
  • Lee Financial's Calithera Biosciences, Inc position peaked at $2K in Q3 2017.
  • 112 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2017.

Based on Lee Financial's 13F filing for Q4 2017, filed 9 Feb 2018.